Compound information
- Natural Products
- ZC253790
- Molecular Formula
- C27H40N6O8
- Molecular Weight
- 576.29076224 g/mol
- Structure
-
- IUPAC Name
- (2R)-2-[[(2R)-1-[(2R)-4-benzyloxy-2-(tert-butoxycarbonylamino)-4-oxo-butanoyl]pyrrolidine-2-carbonyl]amino]-5-guanidino-pentanoic acid
- InChI
- InChI=1S/C27H40N6O8/c1-27(2,3)41-26(39)32-19(15-21(34)40-16-17-9-5-4-6-10-17)23(36)33-14-8-12-20(33)22(35)31-18(24(37)38)11-7-13-30-25(28)29/h4-6,9-10,18-20H,7-8,11-16H2,1-3H3,(H,31,35)(H,32,39)(H,37,38)(H4,28,29,30)/t18-,19-,20-/m1/s1
- InChI Key
- MMUZQFYGDNUZHS-VAMGGRTRSA-N
- SMILES
- CC(C)(C)OC(=O)N[C@H](CC(=O)OCc1ccccc1)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCNC(=N)N)C(=O)O
- Source
- ZINC000106588183
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 41 | Ring Count | 2 |
Heteroatom Count | 14 | Rotatable Bond Count | 13 |
Hydrogen Bond Acceptor Count | 8 | Hydrogen Bond Donor Count | 6 |
Topological Polar Surface Area | 213.24 Å2 | LogP | 0.822 |
LogS | -2.558 | LogD | 0.608 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.008 | Pgp substrate | 0.99 |
HIA | 0.002 | F20 % | 0.825 |
F30 % | 0.015 | Caco-2 | -6.837 |
MDCK | -5.978 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.141 | PPB | 27.363 |
VD | 0.264 | Fu | 0.286 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.0 | CYP1A2 substrate | 0.372 |
CYP2A6 substrate | 0.202 | CYP2B6 substrate | 0.309 |
CYP2C19 inhibitor | 0.028 | CYP2C19 substrate | 0.299 |
CYP2C8 substrate | 0.25 | CYP2C9 inhibitor | 0.104 |
CYP2C9 substrate | 0.402 | CYP2D6 inhibitor | 0.031 |
CYP2D6 substrate | 0.135 | CYP2E1 substrate | 0.296 |
CYP3A4 inhibitor | 0.008 | CYP3A4 substrate | 0.866 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.889 | CL | 4.043 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.083 | Hepatotoxicity | 0.096 |
Mutagenicity | 0.192 | Rat Oral Acute Toxicity | 0.029 |
FDAMDD | 0.282 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.0 | Eye Corrosion | 0.002 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.04 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -2.719 | IGC50 | 2.026 |
LC50FM | 0.549 | LC50DM | 1.076 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.511 | NR-AR-LBD | 0.469 |
NR-AhR | 0.004 | NR-Aromatase | 0.011 |
NR-ER | 0.514 | NR-ER-LBD | 0.364 |
NR-PPAR-gamma | 0.33 | SR-ARE | 0.363 |
SR-ATAD5 | 0.307 | SR-HSE | 0.033 |
SR-MMP | 0.006 | SR-p53 | 0.079 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.